The Role of New Technologies in Defining a Manufacturing Process for PPARα Agonist LY518674†

…, JW Fennell, MA LaPack, RR Rothhaar…

Index: Argentine, Mark D.; Braden, Timothy M.; Czarnik, Jeffrey; Conder, Edward W.; Dunlap, Steven E.; Fennell, Jared W.; LaPack, Mark A.; Rothhaar, Roger R.; Scherer, R. Brian; Schmid, Christopher R.; Vicenzi, Jeffrey T.; Wei, Jeffrey G.; Werner, John A.; Roginski, Robert T. Organic Process Research and Development, 2009 , vol. 13, # 2 p. 131 - 143

Full Text: HTML

Citation Number: 14

Abstract

The impact of several new technologies on the development of a manufacturing process for LY518674 is described. Extensive use of process analytical technology (PAT) throughout development, both at laboratory and pilot-plant scale, enabled data-rich experiments, shortened development cycle times, and obviated the requirement of PAT for process control at larger scale. In situ ReactIR was used to develop a kinetic model for a one-pot ...

~97%

A Convergent Kilogram-Scale Synthesis of the PPARα Agonist L...

[Braden, Timothy M.; Coffey, D. Scott; Doecke, Christopher W.; LeTourneau, Michael E.; Martinelli, Michael J.; Meyer, Christopher L.; Miller, Richard D.; Pawlak, Joseph M.; Pedersen, Steven W.; Schmid, Christopher R.; Shaw, Bruce W.; Staszak, Michael A.; Vicenzi, Jeffrey T. Organic Process Research and Development, 2007 , vol. 11, # 3 p. 431 - 440]

Design and synthesis of a potent and selective triazolone-ba...

[Xu, Yanping; Mayhugh, Daniel; Saeed, Ashraf; Wang, Xiaodong; Thompson, Richard C.; Dominianni, Samuel J.; Kauffman, Raymond F.; Singh, Jaipal; Bean, James S.; Bensch, William R.; Barr, Robert J.; Osborne, John; Montrose-Rafizadeh, Chahrzad; Zink, Richard W.; Yumibe, Nathan P.; Huang, Naijia; Luffer-Atlas, Debra; Rungta, Deepa; Maise, Dale E.; Mantlo, Nathan B. Journal of Medicinal Chemistry, 2003 , vol. 46, # 24 p. 5121 - 5124]